novo-nordisk-fda-warnung-und-who-partnerschaft - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,839 +0.82%

DJIA 48,333 +0.89%

Nasdaq 25,088 +0.78%

DAX 23,923 -0.17%

Gold $4,196 +0.16%

Oil $95.71 -1.01%

BTC $72,439 +1.50%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,221 +0.58%

S&P 500 6,839 +0.82%

DJIA 48,333 +0.89%

Nasdaq 25,088 +0.78%

DAX 23,923 -0.17%

Gold $4,196 +0.16%

Oil $95.71 -1.01%

BTC $72,439 +1.50%

VIX 20.43 -15.85%

EUR/USD 1.1785 -0.02%

ETH $2,221 +0.58%

novo-nordisk-fda-warnung-und-who-partnerschaft

Ozempic pen under dramatic light symbolizing Novo Nordisk FDA warning and GLP-1 safety scrutiny

Pharma & Healthcare·Stocks·Europe

Novo Nordisk FDA warning: Safety shock and WHO funding pivot

By Maik Kemper • Mar 11, 2026

Ozempic pen under dramatic light symbolizing Novo Nordisk FDA warning and GLP-1 safety scrutiny

Pharma & Healthcare·Stocks·Europe

Novo Nordisk FDA warning: Safety shock and WHO funding pivot

By Maik Kemper • Mar 11, 2026

Can the Novo Nordisk FDA warning derail the GLP-1 boom just as a new WHO partnership reshapes the company’s global image? How serious is the…